ReviewSeminars in immunology2023

Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.

Jeremy A O'Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.